miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer
Journal of Cancer · 2024 · 15 (17) · 5622-5635
DOI: 10.7150/jca.96608 ↗At a glance
Journal article in Journal of Cancer, 2024. Written by Wan-Li Duan and 8 co-authors. Institution: Medical Research Center, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China. Cited 20 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Medical Research Center, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China.
- Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261041, China.
- Department of Pathology, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China.
- Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, Shandong, China.
- Department of Medical Oncology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, China.
Cite
APA
Duan, W. L., Wang, X. J., Guo, A., Gu, L. H., Sheng, Z. M., Luo, H., Yang, L. X., Wang, W. H., & Zhang, B. G. (2024). miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. Journal of Cancer, 15(17), 5622-5635. https://doi.org/10.7150/jca.96608
Vancouver
Duan WL, Wang XJ, Guo A, Gu LH, Sheng ZM, Luo H, et al. miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. Journal of Cancer. 2024;15(17):5622-5635. doi:10.7150/jca.96608
BibTeX
@article{Duan2024,
author = {Duan, Wan-Li and Wang, Xue-Jie and Guo, Ai and Gu, Li-Hui and Sheng, Zhi-Mei and Luo, Hao and Yang, Li-Xia and Wang, Wen-Hao and Zhang, Bao-Gang},
title = {miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer},
journal = {Journal of Cancer},
year = {2024},
volume = {15},
number = {17},
pages = {5622--5635},
doi = {10.7150/jca.96608}
}
EUVIMED